Daniel Walker

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial ☆

Jon I. Russell, Philip J. Mease, Timothy R. Smith et al. · Pain · 2008 · 369 citations

Medicine, Pharmacology, Pharmacotherapy +17

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

James T. Hartford, Susan G. Kornstein, Michael R. Liebowitz et al. · International Clinical Psychopharmacology · 2007 · 287 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

A Double-Blind, Randomized Comparison of the Efficacy and Safety of Intramuscular Injections of Olanzapine, Lorazepam, or Placebo in Treating Acutely Agitated Patients Diagnosed With Bipolar Mania

Karena Meehan, Fan Zhang, S.R. David et al. · Journal of Clinical Psychopharmacology · 2001 · 256 citations

Medicine, Pharmacotherapy, Psychiatry +17

Estimation of minimum clinically important difference for pain in fibromyalgia

Philip J. Mease, Michael Spaeth, Daniel J. Clauw et al. · Arthritis Care & Research · 2011 · 167 citations · Full text

Nursing, Pharmacotherapy, Pain Management +15

Olanzapine Versus Ziprasidone: Results of a 28-Week Double-Blind Study in Patients With Schizophrenia

Alan Breier, Paul H. Berg, Jogin H. Thakore et al. · American Journal of Psychiatry · 2005 · 154 citations

Medicine, Pharmacotherapy, Psychiatry +17